Press December 14, 2020 Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971 Read More
Press September 3, 2020 Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor Read More